CS logo
small CS logo
Clinique Notre Dame de Grace

Gosselies, Belgium
Hospital in Charleroi
Chau. de Nivelles 212, 6041 Charleroi

About Clinique Notre Dame de Grace


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Clinique Notre Dame de Grace


During the past decade, Clinique Notre Dame de Grace conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Clinique Notre Dame de Grace" #1 sponsor was "The Lymphoma Academic Research Organisation" with 3 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Cliniques universitaires Saint-Luc- Université Catholique de Louvain" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

Clinical Trials Conditions at Clinique Notre Dame de Grace


According to Clinical.Site data, the most researched conditions in "Clinique Notre Dame de Grace" are "Melanoma (Skin)" (2 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Diffuse Large B-cell Lymphoma" (1 trials), "Follicular Lymphoma" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Clinique Notre Dame de Grace" in a lesser frequency.

Clinical Trials Intervention Types at Clinique Notre Dame de Grace


Most popular intervention types in "Clinique Notre Dame de Grace" are "Drug" (9 trials), "Biological" (2 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Docetaxel" (1 trials), "Erdafitinib" (1 trials), "Fibroblast Growth Factor Receptor inhibitor Clinical Trial Assay (FGFRi CTA)" (1 trials), "Lenalidomide" (1 trials) and "Ofatumumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Clinique Notre Dame de Grace


The vast majority of trials in "Clinique Notre Dame de Grace" are 10 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at Clinique Notre Dame de Grace


Currently, there are NaN active trials in "Clinique Notre Dame de Grace". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Clinique Notre Dame de Grace, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Clinique Notre Dame de Grace, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".